Bayer AG is Reportedly Settling Yasmin Cases PDF Print E-mail
April 13, 2012

Recent news reports indicate Bayer AG will pay at least $110 million to settle about 500 cases alleging its Yasmin line of birth-control pills caused blood clots, which have proved fatal in some instances. While the agreements have not yet been made public, Bayer has reportedly agreed to pay an average of about $220,000 per case. This news arose in the wake of reports that a trial had been postponed while a mediator attempted to negotiate settlements in pending cases.

Last year the the U.S. Food and Drug Administration warned that women taking the pills were 74 percent more likely to suffer blood clots than women on other low-estrogen contraceptives, and some lawyers have indicated at least 50 people have died because of the pills. The company has reportedly indicated it expects additional suits, and Bloomberg News has quoted a Bayer AG filing stating "Bayer will continue to consider the option of settling individual lawsuits in the U.S. on a case-by-case basis."

Parties affected may have a limited time to seek compensation for their injuries. Accordingly, anyone suffering adverse side effects from Yasmin should contact an attorney as quickly as possible.  The law firm of Finkelstein Thompson LLP welcomes inquiries from non-represented parties about their rights and interests in this matter. Finkelstein Thompson's Washington, DC offices can be reached at (877) 337-1050 or by email at This email address is being protected from spam bots, you need Javascript enabled to view it .

http://www.bloomberg.com/news/2012-04-13/bayer-said-to-pay-110-million-in-yaz-birth-control-cases.html